The collaboration combines Salipro Biotech's unique expertise and its Salipro® platform technology to stabilize a challenging drug target and advance ...

CATANIA, Italy I June 10, 2025 I SIFI, a leading international ophthalmic company, today announced that its shareholders have signed an agreement, subject to ...

BERLIN, Germany & CAMBRIDGE, MA, USA I June 11, 2025 I Bayer and the Broad Institute today announced that they have extended their research collaboration ...

STRASBURG, France and CHARLEROI, Belgium I June 11, 2025 I Elkedonia SAS, a company pioneering a novel neuroplastogen approach to develop therapeutic ...

– Series A financing co-led by Omega Funds, Atlas Venture, Lightspeed Venture Partners, BVF Partners, and Cormorant Asset Management, with participation from other leading healthcare funds – ...

BOSTON, MA, USA and LAUSANNE, Switzerland I June 10, 2025 I Alys Pharmaceuticals, Inc. ("Alys"), an immune-dermatology focused company, today announces the ...

COPENHAGEN, Denmark I June 10, 2025 I Adcendo, a clinical-stage biotech company pioneering the development of first and best-in-class ADCs for cancers with a ...

WASHINGTON, DC, USA I June 10, 2025 I Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced the first dose in ...

BOSTON, MA, USA I June 10, 2025 I Curadev Pharma, Inc., a clinical-stage biotechnology company developing novel immuno-oncology therapeutics, and Memorial ...

Presentations will include the latest preclinical data from Factor's engineered iMacrophage program (FACT-112) ...

SINGAPORE and PHILADELPHIA, PA, USA I June 10, 2025 I Nuevocor, a Singapore-headquartered biotechnology company developing cures for cardiomyopathies driven ...

SAN DIEGO, CA, USA I June 10, 2025 I Gyre Therapeutics (“Gyre”) (Nasdaq: GYRE), an innovative, commercial-stage biopharmaceutical company dedicated to ...